BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Mirum Pharmaceuticals, Inc. (MIRM)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Mirum Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:37 pm
Sale		 2024-09-30 13G Mirum Pharmaceuticals, Inc.
MIRM		 BIOTECHNOLOGY VALUE FUND L P 3,075,907
6.400%		 -1,294,117decrease
(-29.61%)		 Filing
2023-09-18
4:35 pm
Purchase		 2023-09-07 13G Mirum Pharmaceuticals, Inc.
MIRM		 BIOTECHNOLOGY VALUE FUND L P 4,370,024
9.400%		 4,370,024increase
(New Position)		 Filing